East Brunswick, NJ, United States of America

Hon-Chung Tsui

This inventor holds 19 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents and 7 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Opko Health, Inc., Schering Corporation, Merck Sharp + Dohme Corp.. Active years: 2006-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hon-Chung Tsui. Retrieved from https://idiyas.com/inventor/hon-chung-tsui

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 19 (Patent Applications = 4)

% Patents Active = 73.7

CIPO Patents = 3

EPO Patents = 7 (Patent Applications = 11)

Average Co-Inventor Count = 8.9

ph-index = 8

Forward Citations = 123(Granted Patents)

Location History:

Kenilworth, NJ (US) (2014)
Shanghai, CN (2014)
East Brunswick, NJ (US) (2006 - 2018)

Company Filing History:

Merck Sharp + Dohme Corp.

patents

Years Active: 2006-2018

Loading Chart...

Areas of Expertise:

NK1 Antagonists

ERK Inhibitors

Pharmaceutical Synthesis

Diaza-Spirans

Trifluoromethyl Compounds

Protein Kinase Inhibitors

Imidazole Carboxamides

Chemical Intermediates

Compound Synthesis

Pharmaceutical Chemistry

Bioactive Compounds

Small Molecule Drugs

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10000493 - Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds (2018-06-19),

2. 9969711 - [object Object] (2018-05-15),

3. 9688693 - [object Object] (2017-06-27),

4. 9469629 - [object Object] (2016-10-18),

5. 9260428 - Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds (2016-02-16),

6. 8796299 - NK1 antagonists (2014-08-05),

7. 8754216 - NK1 antagonists (2014-06-17),

8. 8716483 - Compounds that are ERK inhibitors (2014-05-06),

9. 8623857 - N-phenyl imidazole carboxamide inhibitors of 3-phosphoinositide-dependent protein kinase-1 (2014-01-07),

10. 8552191 - Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds (2013-10-08),

11. 8546404 - Compounds that are ERK inhibitors (2013-10-01),

12. 8273895 - [object Object] (2012-09-25),

13. 8026364 - [object Object] (2011-09-27),

14. 7902366 - [object Object] (2011-03-08),

15. 7709641 - NK1 antagonists (2010-05-04),

Title: The Innovative Journey of Hon-Chung Tsui

Introduction: Hon-Chung Tsui, a talented inventor hailing from East Brunswick, NJ, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents: Hon-Chung Tsui holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, Hon-Chung Tsui has worked for leading tech companies, where he spearheaded research and development projects that have led to cutting-edge inventions and solutions.

Collaborations: Throughout his career, Hon-Chung Tsui has collaborated with top researchers, engineers, and scientists, fostering a culture of innovation and pushing the boundaries of what is possible in the tech industry.

Conclusion: Hon-Chung Tsui's passion for innovation, coupled with his relentless drive to create solutions that make a difference, solidifies his position as a visionary inventor shaping the future of technology.

Profile summary based on public USPTO records.